speb/financial-data huggingface dataset:
CIA income_statement (quarterly, 2025-06-30) — Total Expenses: 58172000.00
CIA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1483474000.00
CIA balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 4327810.00
CIA balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 23725000.00
CIA income_statement (quarterly, 2025-09-30) — +Total Revenue: 62808000.00
CIA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8806000.00
CIA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 20322000.00
CIA cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -3971000.00
CIA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 50265000.00
CIA income_statement (quarterly, 2025-09-30) — Basic EPS: 0.04
CIA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 22671000.00
CIA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -60000.00
CIA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 274430000.00
CIA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 21569000.00
CIA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 53480000.00
CIA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 307000.00
CIA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -4528000.00
CIA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 4673000.00
CIA cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 611000.00
CIA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -755000.00
CIA cash_flow (quarterly, 2025-09-30) — Change In Payable: 935000.00
CIA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 935000.00
CIA cash_flow (quarterly, 2025-09-30) — Change In Receivables: -199000.00
CIA cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 611000.00
CIA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3260000.00
CIA cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -199000.00
CIA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 452000.00
CIA balance_sheet (quarterly, 2025-09-30) — Common Stock: 274430000.00
CIA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 225604000.00
CIA cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 1590000.00
CIA cash_flow (quarterly, 2025-09-30) — Deferred Tax: 1590000.00
CIA cash_flow (quarterly, 2025-09-30) — Depreciation: 192000.00
CIA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 192000.00
CIA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 51570000.00
CIA income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.04
CIA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 2417000.00
CIA cash_flow (quarterly, 2025-09-30) — End Cash Position: 23123000.00
CIA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 307000.00
CIA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 4613000.00
CIA cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 1255000.00
CIA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -89416000.00
CIA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 13291000.00
CIA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 225604000.00
CIA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -4528000.00
CIA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 1357090000.00
CIA balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 84417000.00
CIA balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 84417000.00
CIA income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 37185000.00
CIA income_statement (quarterly, 2025-09-30) — Net Income: 2417000.00
CIA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 2417000.00
CIA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2417000.00
CIA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 2417000.00
CIA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2417000.00
CIA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 2417000.00
CIA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 2417000.00
CIA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -5401000.00
CIA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 35000.00
CIA balance_sheet (quarterly, 2025-09-30) — Net PPE: 9584000.00
CIA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -60000.00
CIA income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 37185000.00
CIA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 225604000.00
CIA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 5224000.00
CIA balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 5224000.00
CIA income_statement (quarterly, 2025-09-30) — Normalized Income: 2417000.00
CIA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 4673000.00
CIA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 1255000.00
CIA income_statement (quarterly, 2025-09-30) — Operating Revenue: 62808000.00
CIA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 50288000.00
CIA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -89416000.00
CIA income_statement (quarterly, 2025-09-30) — Other Gand A: 13291000.00
CIA income_statement (quarterly, 2025-09-30) — Other Income Expense: 1643000.00
CIA balance_sheet (quarterly, 2025-09-30) — Other Payable: 4797000.00
CIA balance_sheet (quarterly, 2025-09-30) — Other Receivables: 12946000.00
CIA balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 31911000.00
CIA balance_sheet (quarterly, 2025-09-30) — Payables: 13603000.00
CIA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 13603000.00
CIA income_statement (quarterly, 2025-09-30) — Policyholder Benefits Gross: 37185000.00
CIA income_statement (quarterly, 2025-09-30) — Pretax Income: 4479000.00
CIA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -70660000.00
CIA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -60000.00
CIA balance_sheet (quarterly, 2025-09-30) — Receivables: 33800000.00
CIA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 192000.00
CIA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 64315000.00
CIA cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 65259000.00
CIA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 13291000.00
CIA balance_sheet (quarterly, 2025-09-30) — Share Issued: 54615810.00
CIA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: -70000.00
CIA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 225604000.00
CIA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 225604000.00
CIA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (quarterly, 2025-09-30) — Tax Provision: 2062000.00
CIA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CIA balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 532000.00
CIA balance_sheet (quarterly, 2025-09-30) — Total Assets: 1742365000.00
CIA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 225604000.00
CIA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 225604000.00
CIA income_statement (quarterly, 2025-09-30) — Total Expenses: 58329000.00
CIA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1516761000.00
CIA balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 4327810.00
CIA balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 23725000.00
CIA income_statement (annual, 2025-12-31) — +Total Revenue: 255616000.00
CIA income_statement (quarterly, 2025-12-31) — +Total Revenue: 72070000.00
CIA balance_sheet (annual, 2025-12-31) — Accounts Payable: 8772000.00
CIA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 8772000.00
CIA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 22173000.00
CIA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 22173000.00
CIA cash_flow (annual, 2025-12-31) — Amortization Of Securities: -16015000.00
CIA cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -5291000.00
CIA income_statement (annual, 2025-12-31) — Basic Average Shares: 50297842.00
CIA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 50297842.00
CIA income_statement (annual, 2025-12-31) — Basic EPS: 0.29
CIA income_statement (quarterly, 2025-12-31) — Basic EPS: 0.15
CIA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 29271000.00
CIA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 23123000.00
CIA cash_flow (annual, 2025-12-31) — Capital Expenditure: -447000.00
CIA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -104000.00
CIA balance_sheet (annual, 2025-12-31) — Capital Stock: 275478000.00
CIA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 275478000.00
CIA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 21422000.00
CIA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 21422000.00
CIA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 49742000.00
CIA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 49742000.00
CIA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4609000.00
CIA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -733000.00
CIA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -19672000.00
CIA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8509000.00
CIA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 17986000.00
CIA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9095000.00
CIA cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -476000.00
CIA cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -92000.00
CIA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -645000.00
CIA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 711000.00
CIA cash_flow (annual, 2025-12-31) — Change In Payable: -1808000.00
CIA cash_flow (quarterly, 2025-12-31) — Change In Payable: -331000.00
CIA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1808000.00
CIA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -331000.00
CIA cash_flow (annual, 2025-12-31) — Change In Receivables: -3511000.00
CIA cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1851000.00
CIA cash_flow (annual, 2025-12-31) — Change In Tax Payable: -476000.00
CIA cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -92000.00
CIA cash_flow (annual, 2025-12-31) — Change In Working Capital: 14568000.00
CIA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 7424000.00
CIA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -3511000.00
CIA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1851000.00
CIA cash_flow (annual, 2025-12-31) — Changes In Cash: -6295000.00
CIA cash_flow (quarterly, 2025-12-31) — Changes In Cash: -147000.00
CIA balance_sheet (annual, 2025-12-31) — Common Stock: 275478000.00
CIA balance_sheet (quarterly, 2025-12-31) — Common Stock: 275478000.00
CIA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 234985000.00
CIA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 234985000.00
CIA cash_flow (annual, 2025-12-31) — Common Stock Payments: -278000.00
CIA cash_flow (annual, 2025-12-31) — Deferred Income Tax: 1467000.00
CIA cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 252000.00
CIA cash_flow (annual, 2025-12-31) — Deferred Tax: 1467000.00
CIA cash_flow (quarterly, 2025-12-31) — Deferred Tax: 252000.00
CIA cash_flow (annual, 2025-12-31) — Depreciation: 741000.00
CIA cash_flow (quarterly, 2025-12-31) — Depreciation: 206000.00
CIA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 741000.00
CIA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 206000.00
CIA income_statement (annual, 2025-12-31) — Diluted Average Shares: 52110714.00
CIA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 52414286.00
CIA income_statement (annual, 2025-12-31) — Diluted EPS: 0.28
CIA income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.14
CIA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 7338000.00
CIA cash_flow (annual, 2025-12-31) — End Cash Position: 22976000.00
CIA cash_flow (quarterly, 2025-12-31) — End Cash Position: 22976000.00
CIA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -4609000.00
CIA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -733000.00
CIA cash_flow (annual, 2025-12-31) — Free Cash Flow: 17539000.00
CIA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 8991000.00
CIA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -140000.00
CIA cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1881000.00
CIA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -88421000.00
CIA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -88421000.00
CIA income_statement (annual, 2025-12-31) — General And Administrative Expense: 53041000.00
CIA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 13598000.00
CIA balance_sheet (annual, 2025-12-31) — Invested Capital: 234985000.00
CIA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 234985000.00
CIA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -19672000.00
CIA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -8509000.00
CIA balance_sheet (annual, 2025-12-31) — Investments And Advances: 1374596000.00
CIA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1374596000.00
CIA balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 82592000.00
CIA balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 82592000.00
CIA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 82592000.00
CIA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 82592000.00
CIA income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 153192000.00
CIA income_statement (quarterly, 2025-12-31) — Loss Adjustment Expense: 42533000.00
CIA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -278000.00
CIA income_statement (annual, 2025-12-31) — Net Income: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Net Income: 7338000.00
CIA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 7338000.00
CIA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 7338000.00
CIA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 7338000.00
CIA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 7338000.00
CIA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 14591000.00
CIA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 7338000.00
CIA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 7338000.00
CIA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -22995000.00
CIA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -9670000.00
CIA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -4331000.00
CIA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -455000.00
CIA balance_sheet (annual, 2025-12-31) — Net PPE: 9835000.00
CIA balance_sheet (quarterly, 2025-12-31) — Net PPE: 9835000.00
CIA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -447000.00
CIA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -104000.00
CIA income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 153192000.00
CIA income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 42533000.00
CIA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 234985000.00
CIA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 234985000.00
CIA balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 5996000.00
CIA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 5996000.00
CIA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5996000.00
CIA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 5996000.00
CIA income_statement (annual, 2025-12-31) — Normalized Income: 14591000.00
CIA income_statement (quarterly, 2025-12-31) — Normalized Income: 7338000.00
CIA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 17986000.00
CIA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 9095000.00
CIA cash_flow (annual, 2025-12-31) — Operating Gains Losses: -140000.00
CIA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1881000.00
CIA income_statement (annual, 2025-12-31) — Operating Revenue: 255616000.00
CIA income_statement (quarterly, 2025-12-31) — Operating Revenue: 72070000.00
CIA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 50297842.00
CIA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 50297842.00
CIA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -88421000.00
CIA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -88421000.00
CIA income_statement (annual, 2025-12-31) — Other Gand A: 53041000.00
CIA income_statement (quarterly, 2025-12-31) — Other Gand A: 13598000.00
CIA income_statement (annual, 2025-12-31) — Other Income Expense: 7066000.00
CIA income_statement (quarterly, 2025-12-31) — Other Income Expense: 1930000.00
CIA balance_sheet (annual, 2025-12-31) — Other Payable: 4186000.00
CIA balance_sheet (quarterly, 2025-12-31) — Other Payable: 4186000.00
CIA balance_sheet (annual, 2025-12-31) — Other Receivables: 90000.00
CIA balance_sheet (quarterly, 2025-12-31) — Other Receivables: 90000.00
CIA balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 28320000.00
CIA balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 28320000.00
CIA balance_sheet (annual, 2025-12-31) — Payables: 12958000.00
CIA balance_sheet (quarterly, 2025-12-31) — Payables: 12958000.00
CIA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 12958000.00
CIA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 12958000.00
CIA income_statement (annual, 2025-12-31) — Policyholder Benefits Gross: 153192000.00
CIA income_statement (quarterly, 2025-12-31) — Policyholder Benefits Gross: 42533000.00
CIA income_statement (annual, 2025-12-31) — Pretax Income: 17470000.00
CIA income_statement (quarterly, 2025-12-31) — Pretax Income: 7864000.00
CIA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -187575000.00
CIA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -77668000.00
CIA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -447000.00
CIA cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -104000.00
CIA balance_sheet (annual, 2025-12-31) — Receivables: 22887000.00
CIA balance_sheet (quarterly, 2025-12-31) — Receivables: 22887000.00
CIA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 741000.00
CIA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 206000.00
CIA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -278000.00
CIA balance_sheet (annual, 2025-12-31) — Retained Earnings: 71653000.00
CIA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 71653000.00
CIA cash_flow (annual, 2025-12-31) — Sale Of Investment: 164580000.00
CIA cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 67998000.00
CIA income_statement (annual, 2025-12-31) — Selling General And Administration: 53041000.00
CIA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 13598000.00
CIA balance_sheet (annual, 2025-12-31) — Share Issued: 54625652.00
CIA balance_sheet (quarterly, 2025-12-31) — Share Issued: 54625652.00
CIA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2774000.00
CIA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1047000.00
CIA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 234985000.00
CIA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 234985000.00
CIA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 234985000.00
CIA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 234985000.00
CIA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (annual, 2025-12-31) — Tax Provision: 2879000.00
CIA income_statement (quarterly, 2025-12-31) — Tax Provision: 526000.00
CIA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.17
CIA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.07
CIA balance_sheet (annual, 2025-12-31) — Taxes Receivable: 624000.00
CIA balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 624000.00
CIA balance_sheet (annual, 2025-12-31) — Total Assets: 1754760000.00
CIA balance_sheet (quarterly, 2025-12-31) — Total Assets: 1754760000.00
CIA balance_sheet (annual, 2025-12-31) — Total Capitalization: 234985000.00
CIA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 234985000.00
CIA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 234985000.00
CIA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 234985000.00
CIA income_statement (annual, 2025-12-31) — Total Expenses: 238146000.00
CIA income_statement (quarterly, 2025-12-31) — Total Expenses: 64206000.00
CIA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1519775000.00
CIA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1519775000.00
CIA balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 5329524.00
CIA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 5329524.00
CIA balance_sheet (annual, 2025-12-31) — Treasury Stock: 23725000.00
CIA balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 23725000.00
CIA income_statement (quarterly, 2026-03-31) — +Total Revenue: 59720000.00
CIA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8522000.00
CIA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 22262000.00
CIA cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -2798000.00
CIA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 50308000.00
CIA income_statement (quarterly, 2026-03-31) — Basic EPS: 0.05
CIA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 22976000.00
CIA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -326000.00
CIA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 275955000.00
CIA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 16966000.00
CIA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 37384000.00
CIA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -705000.00
CIA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3428000.00
CIA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -323000.00
CIA cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 197000.00
CIA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1855000.00
CIA cash_flow (quarterly, 2026-03-31) — Change In Payable: -5015000.00
CIA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -5015000.00
CIA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -89000.00
CIA cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 197000.00
CIA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 635000.00
CIA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -89000.00
CIA cash_flow (quarterly, 2026-03-31) — Changes In Cash: -4456000.00
CIA balance_sheet (quarterly, 2026-03-31) — Common Stock: 275955000.00
CIA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 238668000.00
CIA cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -91000.00
CIA cash_flow (quarterly, 2026-03-31) — Deferred Tax: -91000.00
CIA cash_flow (quarterly, 2026-03-31) — Depreciation: 171000.00
CIA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 171000.00
CIA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 51580000.00
CIA income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.04
CIA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2268000.00
CIA cash_flow (quarterly, 2026-03-31) — End Cash Position: 18520000.00
CIA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -705000.00
CIA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -649000.00
CIA cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -984000.00
CIA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -87483000.00
CIA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 13372000.00
CIA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 238668000.00
CIA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3428000.00
CIA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1359094000.00
CIA balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 83726000.00
CIA balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 83726000.00
CIA income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 36013000.00
CIA income_statement (quarterly, 2026-03-31) — Net Income: 2268000.00
CIA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2268000.00
CIA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2268000.00
CIA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2268000.00
CIA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2268000.00
CIA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2268000.00
CIA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2268000.00
CIA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -3342000.00
CIA cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -705000.00
CIA balance_sheet (quarterly, 2026-03-31) — Net PPE: 9668000.00
CIA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -326000.00
CIA income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 36013000.00
CIA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 238668000.00
CIA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 6219000.00
CIA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 6219000.00
CIA income_statement (quarterly, 2026-03-31) — Normalized Income: 2268000.00
CIA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -323000.00
CIA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -984000.00
CIA income_statement (quarterly, 2026-03-31) — Operating Revenue: 59720000.00
CIA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 50334319.00
CIA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -87483000.00
CIA income_statement (quarterly, 2026-03-31) — Other Gand A: 13372000.00
CIA income_statement (quarterly, 2026-03-31) — Other Income Expense: 1494000.00
CIA balance_sheet (quarterly, 2026-03-31) — Other Payable: 4505000.00
CIA balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1875000.00
CIA balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 20418000.00
CIA balance_sheet (quarterly, 2026-03-31) — Payables: 13027000.00
CIA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 13027000.00
CIA income_statement (quarterly, 2026-03-31) — Policyholder Benefits Gross: 36013000.00
CIA income_statement (quarterly, 2026-03-31) — Pretax Income: 2374000.00
CIA cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -32070000.00
CIA cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -326000.00
CIA balance_sheet (quarterly, 2026-03-31) — Receivables: 24564000.00
CIA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 171000.00
CIA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 73921000.00
CIA cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 28728000.00
CIA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 13372000.00
CIA balance_sheet (quarterly, 2026-03-31) — Share Issued: 54662129.00
CIA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 476000.00
CIA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 238668000.00
CIA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 238668000.00
CIA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CIA income_statement (quarterly, 2026-03-31) — Tax Provision: 106000.00
CIA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.05
CIA balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 427000.00
CIA balance_sheet (quarterly, 2026-03-31) — Total Assets: 1739500000.00
CIA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 238668000.00
CIA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 238668000.00
CIA income_statement (quarterly, 2026-03-31) — Total Expenses: 57346000.00
CIA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1500832000.00
CIA balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 4327810.00
CIA balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 23725000.00
CIA.AX balance_sheet (annual, 2022-03-31) — Cash Equivalents: 101432000.00
CIA.AX cash_flow (annual, 2022-03-31) — Change In Income Tax Payable: -168798000.00
CIA.AX cash_flow (annual, 2022-03-31) — Change In Tax Payable: -168798000.00
CIA.AX balance_sheet (annual, 2022-03-31) — Current Debt: 71995000.00
CIA.AX cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: 176000.00
CIA.AX cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -15444000.00
CIA.AX cash_flow (annual, 2022-03-31) — Net Preferred Stock Issuance: -185000000.00
CIA.AX balance_sheet (annual, 2022-03-31) — Other Current Borrowings: 71995000.00
CIA.AX balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 176000.00
CIA.AX balance_sheet (annual, 2022-03-31) — Other Equity Interest: 22473000.00
CIA.AX balance_sheet (annual, 2022-03-31) — Other Investments: 14158000.00
CIA.AX income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: -752000.00
CIA.AX balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 30777000.00
CIA.AX cash_flow (annual, 2022-03-31) — Preferred Stock Dividend Paid: -57093000.00
CIA.AX cash_flow (annual, 2022-03-31) — Preferred Stock Payments: -185000000.00
CIA.AX cash_flow (annual, 2022-03-31) — Purchase Of Business: -15444000.00
CIA.AX cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -185000000.00
CIA.AX cash_flow (annual, 2022-03-31) — Sale Of Investment: 9468000.00
CIA.AX income_statement (annual, 2022-03-31) — Special Income Charges: 0.00
CIA.AX income_statement (annual, 2023-03-31) — +Operating Expense: 80826000.00
CIA.AX income_statement (annual, 2023-03-31) — +Total Revenue: 1395088000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Accounts Payable: 135318000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Accounts Receivable: 131786000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -214740000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 22796000.00
CIA.AX cash_flow (annual, 2023-03-31) — Asset Impairment Charge: 0.00
CIA.AX income_statement (annual, 2023-03-31) — Basic Average Shares: 517046000.00
CIA.AX income_statement (annual, 2023-03-31) — Basic EPS: 0.39
CIA.AX cash_flow (annual, 2023-03-31) — Beginning Cash Position: 321892000.00
CIA.AX cash_flow (annual, 2023-03-31) — Capital Expenditure: -294664000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 86841000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Capital Stock: 401282000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 326806000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 327118000.00
CIA.AX cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -103344000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Cash Equivalents: 163901000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Cash Financial: 326806000.00
CIA.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 6904000.00
CIA.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -249859000.00
CIA.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: 235984000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Account Payable: -19275000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Income Tax Payable: -60656000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Inventory: -63703000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -9323000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Other Working Capital: -60656000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Payable: -19275000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -19275000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: -10709000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Receivables: -34123000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Tax Payable: -60656000.00
CIA.AX cash_flow (annual, 2023-03-31) — Change In Working Capital: -197789000.00
CIA.AX cash_flow (annual, 2023-03-31) — Changes In Cash: -6971000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Common Stock: 401282000.00
CIA.AX cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -103344000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Common Stock Equity: 1262704000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Construction In Progress: 29264000.00
CIA.AX income_statement (annual, 2023-03-31) — Cost Of Revenue: 943806000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Current Accrued Expenses: 20711000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Current Assets: 738019000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 13411000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Current Debt: 27080000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 40491000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Current Liabilities: 205658000.00
CIA.AX cash_flow (annual, 2023-03-31) — Deferred Income Tax: 90735000.00
CIA.AX cash_flow (annual, 2023-03-31) — Deferred Tax: 90735000.00
CIA.AX cash_flow (annual, 2023-03-31) — Depreciation: 121044000.00
CIA.AX cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 121044000.00
CIA.AX cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 121044000.00
CIA.AX income_statement (annual, 2023-03-31) — Diluted Average Shares: 527666000.00
CIA.AX income_statement (annual, 2023-03-31) — Diluted EPS: 0.38
CIA.AX income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 200707000.00
CIA.AX income_statement (annual, 2023-03-31) — EBIT: 360633000.00
CIA.AX income_statement (annual, 2023-03-31) — EBITDA: 481677000.00
CIA.AX cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 11885000.00
CIA.AX cash_flow (annual, 2023-03-31) — End Cash Position: 326806000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 14751000.00
CIA.AX cash_flow (annual, 2023-03-31) — Financing Cash Flow: 6904000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Foreign Currency Translation Adjustments: 430000.00
CIA.AX cash_flow (annual, 2023-03-31) — Free Cash Flow: -58680000.00
CIA.AX cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -176000.00
CIA.AX cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 0.00
CIA.AX income_statement (annual, 2023-03-31) — Gain On Sale Of Security: -6451000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 430000.00
CIA.AX income_statement (annual, 2023-03-31) — General And Administrative Expense: 50809000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 7866000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Gross PPE: 1593835000.00
CIA.AX income_statement (annual, 2023-03-31) — Gross Profit: 451282000.00
CIA.AX cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 115759000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Income Tax Payable: 0.00
CIA.AX income_statement (annual, 2023-03-31) — Insurance And Claims: 9735000.00
CIA.AX income_statement (annual, 2023-03-31) — Interest Expense: 14088000.00
CIA.AX income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 14088000.00
CIA.AX income_statement (annual, 2023-03-31) — Interest Income: 6291000.00
CIA.AX income_statement (annual, 2023-03-31) — Interest Income Non Operating: 6291000.00
CIA.AX cash_flow (annual, 2023-03-31) — Interest Paid Supplemental Data: 26138000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Inventory: 167670000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Invested Capital: 1710905000.00
CIA.AX cash_flow (annual, 2023-03-31) — Investing Cash Flow: -249859000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 14751000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Investments And Advances: 14751000.00
CIA.AX cash_flow (annual, 2023-03-31) — Issuance Of Debt: 219167000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 73430000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Long Term Debt: 448201000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 521631000.00
CIA.AX cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 219167000.00
CIA.AX cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -106130000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Long Term Provisions: 85508000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 64739000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
CIA.AX balance_sheet (annual, 2023-03-31) — Net Debt: 121395000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 7867000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Income: 200707000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 200707000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 200707000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 200707000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 200707000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 200707000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 200707000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -2455000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Interest Income: -17513000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 31070000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 113037000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 113037000.00
CIA.AX income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -17513000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -4606000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 13735000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Net PPE: 1379095000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -292209000.00
CIA.AX cash_flow (annual, 2023-03-31) — Net Preferred Stock Issuance: 0.00
CIA.AX balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 1254838000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 226341000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 10614000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 215727000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 166943000.00
CIA.AX income_statement (annual, 2023-03-31) — Normalized EBITDA: 488128000.00
CIA.AX income_statement (annual, 2023-03-31) — Normalized Income: 205222700.00
CIA.AX cash_flow (annual, 2023-03-31) — Operating Cash Flow: 235984000.00
CIA.AX cash_flow (annual, 2023-03-31) — Operating Gains Losses: 7691000.00
CIA.AX income_statement (annual, 2023-03-31) — Operating Income: 370456000.00
CIA.AX income_statement (annual, 2023-03-31) — Operating Revenue: 1422567000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 517193000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 27080000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Equity Interest: 22288000.00
CIA.AX income_statement (annual, 2023-03-31) — Other Gand A: 11295000.00
CIA.AX income_statement (annual, 2023-03-31) — Other Income Expense: -6398000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 7866000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Inventories: 51704000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Investments: 14751000.00
CIA.AX cash_flow (annual, 2023-03-31) — Other Non Cash Items: 5527000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 8595000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 13427000.00
CIA.AX income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 53000.00
CIA.AX income_statement (annual, 2023-03-31) — Other Operating Expenses: 11038000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Properties: 424467000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Receivables: 9192000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 312000.00
CIA.AX income_statement (annual, 2023-03-31) — Other Taxes: 7116000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Payables: 135318000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 156029000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9138000.00
CIA.AX cash_flow (annual, 2023-03-31) — Preferred Stock Payments: 0.00
CIA.AX balance_sheet (annual, 2023-03-31) — Prepaid Assets: 43051000.00
CIA.AX income_statement (annual, 2023-03-31) — Pretax Income: 346545000.00
CIA.AX cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 1817000.00
CIA.AX cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
CIA.AX cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -2455000.00
CIA.AX cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
CIA.AX cash_flow (annual, 2023-03-31) — Purchase Of PPE: -292209000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Raw Materials: 115966000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Receivables: 200180000.00
CIA.AX income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 943806000.00
CIA.AX income_statement (annual, 2023-03-31) — Reconciled Depreciation: 121044000.00
CIA.AX cash_flow (annual, 2023-03-31) — Repayment Of Debt: -106130000.00
CIA.AX cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: 0.00
CIA.AX income_statement (annual, 2023-03-31) — Research And Development: 11863000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Retained Earnings: 815908000.00
CIA.AX income_statement (annual, 2023-03-31) — Salaries And Wages: 29779000.00
CIA.AX cash_flow (annual, 2023-03-31) — Sale Of Investment: 31070000.00
CIA.AX cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
CIA.AX income_statement (annual, 2023-03-31) — Selling General And Administration: 50809000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Share Issued: 517193000.00
CIA.AX income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
CIA.AX cash_flow (annual, 2023-03-31) — Stock Based Compensation: 8662000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1262704000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1254838000.00
CIA.AX income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -1935300.00
CIA.AX income_statement (annual, 2023-03-31) — Tax Provision: 145838000.00
CIA.AX income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
CIA.AX balance_sheet (annual, 2023-03-31) — Taxes Receivable: 59202000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Assets: 2315269000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Capitalization: 1710905000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Debt: 562122000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1262704000.00
CIA.AX income_statement (annual, 2023-03-31) — Total Expenses: 1024632000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1052565000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1577250000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 846907000.00
CIA.AX income_statement (annual, 2023-03-31) — Total Operating Income As Reported: 371310000.00
CIA.AX income_statement (annual, 2023-03-31) — Total Other Finance Cost: 9716000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
CIA.AX income_statement (annual, 2023-03-31) — Total Unusual Items: -6451000.00
CIA.AX income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -6451000.00
CIA.AX cash_flow (annual, 2023-03-31) — Unrealized Gain Loss On Investment Securities: -593000.00
CIA.AX balance_sheet (annual, 2023-03-31) — Working Capital: 532361000.00
CIA.AX income_statement (annual, 2023-03-31) — Write Off: 0.00
CIA.AX income_statement (annual, 2024-03-31) — +Operating Expense: 88775000.00
CIA.AX income_statement (annual, 2024-03-31) — +Total Revenue: 1524294000.00
CIA.AX balance_sheet (annual, 2024-03-31) — Accounts Payable: 203026000.00
CIA.AX balance_sheet (annual, 2024-03-31) — Accounts Receivable: 71560000.00
CIA.AX balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -319540000.00
CIA.AX balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 17372000.00
CIA.AX cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 2744000.00
CIA.AX income_statement (annual, 2024-03-31) — Basic Average Shares: 517579000.00
CIA.AX income_statement (annual, 2024-03-31) — Basic EPS: 0.45
CIA.AX cash_flow (annual, 2024-03-31) — Beginning Cash Position: 326806000.00
CIA.AX cash_flow (annual, 2024-03-31) — Capital Expenditure: -343274000.00
CIA.AX balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 76978000.00
CIA.AX balance_sheet (annual, 2024-03-31) — Capital Stock: 409785000.00
CIA.AX balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 400061000.00